Impact of a Preexisting STEMI Network in Improving STEMI Diagnostic and Treatment in the Community after the Introduction of a National Program of Interventional Treatment in Acute myocardial Infarction
Introduction: According to European guidelines, ST elevation acute myocardial infarction should be treated by immediate reperfusion, if diagnosed within 12 hours from the onset of symptoms. We aimed to show the impact of a well-functioning pre-existing STEMI network in improving the results of a national program dedicated to the invasive treatment of AMI.
Methods: We followed the comparison between primary PCI rates and STEMI-related mortality in two regions, after the introduction of a nationwide program for the interventional treatment of acute myocardial infarction: region A, where the territory has been appropriately prepared via previous organizational measures in the network, and region B, where the territory has not been previously prepared.
Results: In 2011, one year after the initiation of the national program, a primary PCI rate of 12.1%, a thrombolysis rate of 10.1% and a no-reperfusion treatment rate of 77.8% have been found in these new centers for patients arriving <12 h from symptoms onset. This has been reflected in a mortality of 23.07% for “early presentations” in these new centers in 2011. In comparison, data from the territorial hospitals of the registry (only those without cathlab facilities, similar to the new centers) showed in 2011 a 73.85% primary PCI rate, 12.09% thrombolysis rate and a 14.07% conservative treatment rate, reflected in a mortality of 6.81% for “early presentations” in the registry centers.
Conclusions: The national strategy for reduction of STEMI related mortality via implementation of primary PCI, started in 2010, had a significant impact especially in that region where the territory was previously prepared with appropriate organizational efforts, including educational and logistic measures.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Hasin Y Danchin N Filippatos GS et al. Recommendations for the structure organization and operation of intensive cardiac care units. Eur Heart J. 2005;26:1676-1682.
2. Van der Werf F Bax J Betriu A et al ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force of Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909-2945.
3. Gibson CM Pride YB Frederic PD et al. Trends in reperfusion strategies door-to needle and door-to balloon times and in-hospital mortality among patients with ST elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008;156:1035-1044.
4. McDermott KA Helfrich CD Sales AE Rumsfeld JS Ho PM Fihn SD. A review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial infarction. J Gen Intern Med. 2008;23:1246–1256.
5. Bauer T Hoffman R Junger C et al. Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice. Clin Res Cardiol. 2009;98:171–178.
6. Granger CB Goldberg RJ Dabbous O et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345-2353.
7. Andersen HR Nielsen TT Rasmussen K et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733-742.
8. Keeley EC Boura JA Grines CL. Primaty angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomized trials. Lancet. 2003;361:13-20.
9. Widimsky P Budesinsky T Vorac D et al PRAGUE study group investigator. Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicenter trial - PRAGUE -2. Eur Heart J. 2003;24:94-104.
10. Gitt AK Bueno H Danchin N et al. The role of cardiac registries in evidence-based medicine. Eur Heart J. 2010;31:525-529.
11. Ting HH Rihal CS Gersh BJ et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI protocol. Circulation. 2007;116:729-736.
12. Ahmar W Quarin T Ajani A Kennedy M Grigg L. Improvement in door-to-balloon times in management of acute ST-segment elevation myocardial infarction STEMI through the initiation of ‘Code AMI’. Int Med J. 2008;38:714-718.
13. Holmes DR Bell MR Gersh BJ et al. Systems of care to improve timeliness of reperfusion therapy for ST-segment elevation myocardial infarction off hours. J Am Coll Cardiol Interv. 2008;1:88-96.
14. Jollis JG Roettig ML Aluko AO et al. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA. 2007;298:2371-2380.
15. Widimsky P Wijns W Fajadet J et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31:943-957.
16. Mendoza C Bhatt MR Virani Schob AH. Management of failed thrombolysis after acute myocardial infarction: An overview of current treatment options. International Journal of Cardiology. 2007;114;3:291-299.
17. Tatu-Chitoiu G Cinteza M Dorobantu M et al. In-hospital case fatality rates for acute myocardial infarction in Romania. CMAJ. 2009;180(12):1207-1213.
18. Brieger D Eagle KA Goodman SG et al. Acute coronary syndromes without chest pain an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest. 2004;126:461-469.
19. Mandelzweig L Battler A Boyko V et al. The second Euro Heart Survey on acute coronary syndromes: characteristics treatment and outcome of patients with ACS in Europe and Mediteraneea Basin in 2004. Eur Heart J. 2006;27:2285-2293.
20. Cubeddu RJ Cruz-Gonzalez I Kiernan TJ et al. ST-elevation myocardial infarction mortality in a major academic center “on-” versus “off-”hours. J Invasive Cardiol. 2009;21:518-523.